Wavemaker wins the media account for Ozempic maker Novo Nordisk
B&T reports the agency Wavemaker has taken over media duties for Novo Nordisk, the company behind Ozempic and Wegovy.
Recap by typeshit. Post by B&T on X.
See it on X
More peptides
-
Italian obesity doctors say patients quit GLP-1s too soon as oral pills near 
Italian obesity doctors say patients quit GLP-1s too soon as oral pills near
At the SIO congress in Palermo, specialists flagged short real-world adherence and no national reimbursement in Italy. Oral semaglutide and orforglipron are expected there in 2027.
-
Ryan Sims looks back five months after losing 35 pounds on retatrutide 
11:54
Ryan Sims looks back five months after losing 35 pounds on retatrutide
Ryan Sims of Optimal Health Project gives a follow-up on how things have gone in the months since his 35-pound loss on the experimental drug.
-
Costa Rica's public healthcare system weighs covering Ozempic and other weight loss drugs Costa Rica's public healthcare system weighs covering Ozempic and other weight loss drugs
The Tico Times reports Costa Rica's public system is considering offering GLP-1 weight loss drugs to patients. Tap through for where the discussion stands.
-
Fiscal.ai shares a chart saying Eli Lilly leads Novo in weight loss drugs Fiscal.ai shares a chart saying Eli Lilly leads Novo in weight loss drugs
Fiscal.ai posted a chart comparing Lilly and Novo Nordisk and says Lilly is pulling ahead in the obesity drug market. Only the chart is shared, with no other detail.
-
Analysis puts Saudi public cost of GLP-1 obesity drugs at up to SAR 18.9B over 10 years peptides typeshitPricesAnalysis puts Saudi public cost of GLP-1 obesity drugs at up to SAR 18.9B over 10 years
Researchers from Taif and Umm Al-Qura universities say limiting coverage to patients with a related condition would cut the public bill to SAR 10.96 billion.
-
U.S. News survey ties behavioral support to the biggest GLP-1 telehealth weight loss peptides typeshitResearchU.S. News survey ties behavioral support to the biggest GLP-1 telehealth weight loss
Among 1,200+ telehealth users who lost over 20% of body weight, 52% had behavioral or psychological support. High prices drove most platform switching.
